TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is Under Scrutiny From the SEC

    The list of problems grows for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 More Game-Changing Updates

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) likes to keep investors guessing.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is it a Turnaround Candidate or Is More Trouble Ahead?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is both loved and loathed by investors, and recent events might be the start of…

    Read more »

    The Motley Fool
    Investing

    Was Andrew Left Right About Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have some explaining to do.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Shares Are Down 19% in 2 Days

    Analyst David Maris is not a fan of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Worth the Risk?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has had a devastating past few months, and while the chain of bad news may…

    Read more »

    The Motley Fool
    Investing

    3 Reasons Valeant Pharmaceuticals Intl Inc. Is in for a Rough Ride on Thursday

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is set to testify before Congress. It won't be fun for the company.

    Read more »

    The Motley Fool
    Investing

    Hillary Clinton Is Targeting Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a number of targets on its back.

    Read more »

    The Motley Fool
    Investing

    More Bad News for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will be subject to even more public scrutiny.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Plan for 2016

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will look very different in 2016.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Good News and the Bad News

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in the midst of a very big week.

    Read more »

    The Motley Fool
    Investing

    This Week Could Make or Break Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will host its investor day on Wednesday. The stakes couldn't be higher.

    Read more »